Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice
Stanislav Pantelyushin, … , Alexander A. Navarini, Burkhard Becher
Stanislav Pantelyushin, … , Alexander A. Navarini, Burkhard Becher
Published May 1, 2012
Citation Information: J Clin Invest. 2012;122(6):2252-2256. https://doi.org/10.1172/JCI61862.
View: Text | PDF
Brief Report Dermatology Article has an altmetric score of 5

Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice

  • Text
  • PDF
Abstract

Psoriasis is a common, relapsing inflammatory skin disease characterized by erythematous scaly plaques. Histological manifestations of psoriasis include keratinocyte dysregulation and hyperproliferation, elongated rete ridges, and inflammatory infiltrates consisting of T cells, macrophages, dendritic cells, and neutrophils. Despite the availability of new effective drugs to treat psoriasis, the underlying mechanisms of pathogenesis are still poorly understood. Recent studies have shown that Aldara cream, used to treat benign skin abnormalities, triggers psoriasis-like disease in humans and mice and have implicated Th17 cells in disease initiation. Using this as a model, we found a predominant role for the Th17 signature cytokines IL-17A, IL-17F, and IL-22 in psoriasiform plaque formation in mice. Using gene-targeted mice, we observed that loss of Il17a, Il17f, or Il22 strongly reduced disease the severity of psoriasis. However, we found that Th17 cells were not the primary source of these pathogenic cytokines. Rather, IL-17A, IL-17F, and IL-22 were produced by a skin-invading population of γδ T cells and RORγt+ innate lymphocytes. Furthermore, our findings establish that RORγt+ innate lymphocytes and γδ T cells are necessary and sufficient for psoriatic plaque formation in an experimental disease model that closely resembles human psoriatic plaque formation.

Authors

Stanislav Pantelyushin, Stefan Haak, Barbara Ingold, Paulina Kulig, Frank L. Heppner, Alexander A. Navarini, Burkhard Becher

×

Figure 1

IL-17A, IL-17F, and IL-22 are important for psoriatic plaque formation.

Options: View larger image (or click on image) Download as PowerPoint
IL-17A, IL-17F, and IL-22 are important for psoriatic plaque formation.
...
(A and B) WT mice were treated with Aldara and anti–IL-12/23p40 mAb or isotype control on day 2. (A) Kinetics of skin inflammation as percent increase in thickness over 6 days (n = 4). (B) Skin sections were stained with H&E and anti-MPO. Scale bars: 100 μm. (C) Dot plots display the secretion of IL-17A, IL-17F, and IL-22 among CD45+ cells from the skin of wild-type mice on day 5 of Aldara treatment. (D and E) WT, Il17a–/–, Il17f–/–, and Il22–/– mice were treated with Aldara or control cream for 5 days. Scatter plot shows percent increase in skin thickness (n = 4) (D). Skin sections of Aldara-treated mice taken on day 6 (E) were stained with H&E. Scale bar: 100 μm. (F) IL-17AF heterodimer concentration was measured in the supernatant of LN or skin cells cultured for 24 hours using IL-17AF FlowCytomix Simplex kit (eBioscience). Each experiment was performed independently at least 3 times. *P < 0.05, **P < 0.01, #P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 2 patents
On 1 Facebook pages
Highlighted by 1 platforms
224 readers on Mendeley
See more details